1. Home
  2. KALA vs KSCP Comparison

KALA vs KSCP Comparison

Compare KALA & KSCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KALA
  • KSCP
  • Stock Information
  • Founded
  • KALA 2009
  • KSCP 2013
  • Country
  • KALA United States
  • KSCP United States
  • Employees
  • KALA N/A
  • KSCP N/A
  • Industry
  • KALA Biotechnology: Pharmaceutical Preparations
  • KSCP Telecommunications Equipment
  • Sector
  • KALA Health Care
  • KSCP Telecommunications
  • Exchange
  • KALA Nasdaq
  • KSCP Nasdaq
  • Market Cap
  • KALA 26.2M
  • KSCP 29.3M
  • IPO Year
  • KALA 2017
  • KSCP 2022
  • Fundamental
  • Price
  • KALA $4.82
  • KSCP $4.89
  • Analyst Decision
  • KALA Strong Buy
  • KSCP Strong Buy
  • Analyst Count
  • KALA 3
  • KSCP 3
  • Target Price
  • KALA $14.00
  • KSCP $15.67
  • AVG Volume (30 Days)
  • KALA 64.7K
  • KSCP 218.1K
  • Earning Date
  • KALA 08-05-2025
  • KSCP 08-13-2025
  • Dividend Yield
  • KALA N/A
  • KSCP N/A
  • EPS Growth
  • KALA N/A
  • KSCP N/A
  • EPS
  • KALA N/A
  • KSCP N/A
  • Revenue
  • KALA N/A
  • KSCP $11,468,000.00
  • Revenue This Year
  • KALA N/A
  • KSCP $16.17
  • Revenue Next Year
  • KALA N/A
  • KSCP $39.02
  • P/E Ratio
  • KALA N/A
  • KSCP N/A
  • Revenue Growth
  • KALA N/A
  • KSCP N/A
  • 52 Week Low
  • KALA $2.92
  • KSCP $2.45
  • 52 Week High
  • KALA $11.20
  • KSCP $28.57
  • Technical
  • Relative Strength Index (RSI)
  • KALA 55.88
  • KSCP 36.19
  • Support Level
  • KALA $4.36
  • KSCP $4.90
  • Resistance Level
  • KALA $5.90
  • KSCP $5.18
  • Average True Range (ATR)
  • KALA 0.48
  • KSCP 0.30
  • MACD
  • KALA 0.05
  • KSCP -0.11
  • Stochastic Oscillator
  • KALA 39.81
  • KSCP 5.97

About KALA KALA BIO Inc.

Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.

About KSCP Knightscope Inc.

Knightscope Inc is a security technology company based in Silicon Valley. It designs, develops, manufactures, markets, and supports Autonomous Security Robots (ASRs), autonomous charging stations, the proprietary Knightscope Security Operations Center software user interface, Emergency Communication Devices platform with real-time on-site data collection and analysis and a proprietary interface for both indoor and outdoor usage. In addition, it developed and operates the Knightscope Security Operations Center (KSOC) which allows real-time data access, a service accessible to all its clients.

Share on Social Networks: